Fig. 2From: Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimenSignificant Baseline DNA Methylation Differences reveal less methylation in refractory disease of AZA containing treatment regimens. A Volcano Plot illustrating methylation differences between AZA-sensitive and AZA-resistant (Experimental Therapy) as well as B induction sensitive and induction resistant patients (Standard Therapy). Mean methylation difference between the 2 groups is represented on the x axis and statistical significance (-log10 unadjusted p-value) on the y axis. Negative binomial distribution-based testing with edgeR identified 1755 DMRs, indicated by red and blue dots (FDR < 5% with adjustment for multiple testing)Back to article page